| |
|
 |
 |
  |
 |
 |
|
 |
 |
| |
|
|
| |
PharmEste is a private biopharmaceutical company focused on the discovery and development of Transient Receptor Potential
(TRP) channel therapeutics for the treatment of neuropathic pain,
overactive bladder and other TRP-mediated diseases.
PharmEste has its first clinical drug candidate, PHE377, in Phase I clinical
studies for the treatment of neuropathic pain, a second generation of TRPV1
antagonists under lead optimization stage and a discovery program on other TRPs.
PharmEste Business Unit is located in Milan and Laboratories in Ferrara.
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
Meet us |
| |
March 8-10, 2010 |
| |
BIO-Spring 2010 Barcelona - Spain
|
|
|
|
|
Chronology & News |
| |
|
|
|
|
|
|
|
| |
| |
PharmEste Business Unit: Technology Park:
Scientific-Technological Campus, Block B,
Ground Floor: |
Via Ariosto 21- 20091 Bresso (Milan), Italy
Tel. +39 02 66524550; Fax +39 02 66524547 P.I. 01600600389
Via Saragat 1 - 44100 Ferrara, Italy
|
|
| |
|
|
|
|
|
| |
 |
|
 |